Show simple item record

dc.contributor.authorRupcic, Zeljka
dc.contributor.authorHüttel, Stephan
dc.contributor.authorBernecker, Steffen
dc.contributor.authorKanaki, Sae
dc.contributor.authorStadler, Marc
dc.date.accessioned2018-06-29T14:34:33Z
dc.date.available2018-06-29T14:34:33Z
dc.date.issued2018-06-05
dc.identifier.issn2306-5354
dc.identifier.pmid29874859
dc.identifier.doi10.3390/bioengineering5020042
dc.identifier.urihttp://hdl.handle.net/10033/621418
dc.description.abstractA method was established for the production of 1.2-fold and 4.2-fold increased amounts of the antiviral and central nervous system-active lantipeptides, labyrinthopeptins A1 and A2, respectively, isolated from the actinobacteriumen_US
dc.rightsAttribution-NonCommercial-ShareAlike 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/3.0/us/*
dc.subjectanti-viral agentsen_US
dc.subjectbioprocessen_US
dc.subjectcentral nervous systemen_US
dc.subjectlantibioticsen_US
dc.subjectoptimization productionen_US
dc.subjectreversed phase-high performance liquid chromatographyen_US
dc.subjectscale-upen_US
dc.titleLarge Scale Production and Downstream Processing of Labyrinthopeptins from the Actinobacterium .en_US
dc.typeArticleen_US
dc.contributor.departmentHelmholtz-Zentrum für Infektionsforschung GmbH, Inhoffenstr. 7, 38124 Braunschweig, Germany.en_US
refterms.dateFOA2018-06-29T14:34:34Z
dc.source.journaltitleBioengineering (Basel, Switzerland)


Files in this item

Thumbnail
Name:
Rupcic et al.pdf
Size:
704.1Kb
Format:
PDF
Description:
Open Access publication

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-ShareAlike 3.0 United States
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-ShareAlike 3.0 United States